| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Streptococci (Viridans group) |
0.03 |
0.5 |
<0.03 － 4 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin)  |
1060 |
| Streptococci (Viridans group) |
>0.03 |
>1 |
≤0.015 － >1 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
73 |
| Streptococci (Viridans group) |
0.03 |
1 |
≤0.015 － >32 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
371 |
| Streptococci (Viridans group) |
0.06 |
0.06 |
0.015 － 0.12 |
Telavancin (TD-6424, Vibativ) |
73 |
| Streptococci (Viridans group) |
0.06 |
0.12 |
0.002 － 2 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
950 |
| Streptococci (Viridans group) |
0.06 |
0.25 |
? － ? |
Ceftobiprole (Zeftera) |
942 |
| Streptococci (Viridans group) |
0.06 |
1 |
≤0.008 － 8 |
Cefditoren (Spectracef) |
119 |
| Streptococci (Viridans group) |
0.06 |
2 |
≤0.06 － >2 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
73 |
| Streptococci (Viridans group) |
0.06 |
2 |
≤0.06 － 32 |
Ceftriaxone (Rocephin) |
371 |
| Streptococci (Viridans group) |
>0.06 |
>8 |
≤0.06 － >8 |
Clindamycin (Cleocin) |
265 |
| Streptococci (Viridans group) |
0.064 |
1 |
? － ? |
Imipenem |
126 |
| Streptococci (Viridans group) |
0.12 |
0.25 |
≤0.015 － 0.5 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
1396 |
| Streptococci (Viridans group) |
0.12 |
0.25 |
0.03 － 1 |
Teicoplanin (Targocid) |
67 |
| Streptococci (Viridans group) |
0.12 |
0.5 |
≤0.008 － 16 |
Ceftriaxone (Rocephin) |
412 |
| Streptococci (Viridans group) |
0.12 |
0.5 |
≤0.12 － 0.5 |
SCH27899 |
129 |
| Streptococci (Viridans group) |
0.12 |
0.5 |
≤0.12 － 4 |
Clindamycin (Cleocin) |
371 |
| Streptococci (Viridans group) |
0.12 |
0.5 |
≤0.12 － 4 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
371 |
| Streptococci (Viridans group) |
0.12 |
1 |
≤0.12 － >8 |
Cefepime (Maxipime) |
412 |
| Streptococci (Viridans group) |
0.12 |
2 |
≤0.015 － 4 |
Ceftriaxone (Rocephin) |
73 |
| Streptococci (Viridans group) |
0.12 |
2 |
≤0.12 － >4 |
Cefuroxime (Kefurox, Zinacef) |
73 |
| Streptococci (Viridans group) |
0.12 |
4 |
0.06 － 4 |
Moxifloxacin (BAY 12-8039, Avelox) |
1060 |
| Streptococci (Viridans group) |
>0.12 |
>8 |
≤0.06 － >8 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
265 |
| Streptococci (Viridans group) |
0.19 |
2 |
? － ? |
Ceftriaxone (Rocephin) |
126 |
| Streptococci (Viridans group) |
0.25 |
0.25 |
0.12 － 0.5 |
Vancomycin (Vancocyn, Lyphocin) |
1060 |
| Streptococci (Viridans group) |
0.25 |
0.5 |
0.03 － 4 |
LBM415 (NVP-PDF-713, VIC-10495) |
265 |
| Streptococci (Viridans group) |
0.25 |
0.5 |
<0.12 － 0.5 |
Quinupristin/Dalfopristin (Synercid) |
1060 |
| Streptococci (Viridans group) |
0.25 |
1 |
0.06 － 1 |
Daptomycin + 75 μg/ml Ca++ |
67 |
| Streptococci (Viridans group) |
0.25 |
1 |
0.12 － 2 |
Daptomycin + 50 μg/ml Ca++ |
67 |